Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Multiple Myeloma
NCT00083577Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Feb 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of thalidomide in multiple myeloma (MM), sponsored by University of Arkansas. Primary endpoints: Tumor Response, Overall Survival and 1 more. Started Feb 1998; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00083577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083577.